Literature DB >> 29777258

Development of a two-stage in vitro model system to investigate the mineralization mechanisms involved in idiopathic stone formation: stage 1-biomimetic Randall's plaque using decellularized porcine kidneys.

Archana C Lovett1, Saeed R Khan2, Laurie B Gower3.   

Abstract

Idiopathic calcium oxalate (CaOx) stone formers form stones that are commonly attached to calcium phosphate (CaP) deposits in the renal tissue, known as Randall's plaques (RP). Plaques are suggested to originate in the renal tubular basement membrane, where they exhibit a morphology of concentrically laminated apatitic spherules, while in the interstitial regions, the collagen fibrils and vesicles become mineralized. We hypothesize that these minerals might form by non-classical crystallization mechanisms, such as via amorphous precursors, some of which might originate from a polymer-induced liquid-precursor (PILP) process. Thus, our goal is to identify mineralogical 'signatures' of various stone formation mechanisms. To do this for idiopathic CaOx stones, we are developing a two-stage model system of CaP-CaOx composite stones, consisting of stage (1) CaP mineralized plaque, followed by stage (2) CaOx overgrowth into a stone. For the studies presented here, decellularized porcine kidneys were mineralized with CaP using polyaspartic acid or the protein osteopontin (OPN) to induce the PILP process and create biomimetic RP. Analysis of the PILP-mineralized tissues shows features that resemble the native plaques, including mineral spherules and collagen with intrafibrillar mineral. In contrast, the classical crystallization produced large apatitic spherulites, which is a very different morphology, but one which is also found in some stones. An alternative hypothesis regarding Randall's plaque, and if or when it becomes pathological, is discussed.

Entities:  

Keywords:  Biomimetic model system; Kidney Stones; Osteopontin; PILP; Randall’s plaque; Urolithiasis

Mesh:

Substances:

Year:  2018        PMID: 29777258      PMCID: PMC7015270          DOI: 10.1007/s00240-018-1060-z

Source DB:  PubMed          Journal:  Urolithiasis        ISSN: 2194-7228            Impact factor:   3.436


  67 in total

1.  Nephrolithiasis: site of the initial solid phase.

Authors:  David A Bushinsky
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

2.  A new paradigm for biomineral formation: mineralization via an amorphous liquid-phase precursor.

Authors:  Matthew J Olszta; Damian J Odom; Elliot P Douglas; Laurie B Gower
Journal:  Connect Tissue Res       Date:  2003       Impact factor: 3.417

3.  An improved method to prepare hyaluronic acid and type II collagen composite matrices.

Authors:  Tetsushi Taguchi; Toshiyuki Ikoma; Junzo Tanaka
Journal:  J Biomed Mater Res       Date:  2002-08

4.  Randall's plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle.

Authors:  Andrew P Evan; James E Lingeman; Fredric L Coe; Joan H Parks; Sharon B Bledsoe; Youzhi Shao; Andre J Sommer; Ryan F Paterson; Ramsay L Kuo; Marc Grynpas
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

Review 5.  The primary stone event: a new hypothesis involving a vascular etiology.

Authors:  Marshall L Stoller; Maxwell V Meng; Harrison M Abrahams; John P Kane
Journal:  J Urol       Date:  2004-05       Impact factor: 7.450

Review 6.  Modulators of urinary stone formation.

Authors:  Saeed R Khan; Dirk J Kok
Journal:  Front Biosci       Date:  2004-05-01

7.  Enhancing the biological activity of immobilized osteopontin using a type-1 collagen affinity coating.

Authors:  Stephanie M Martin; Jeffrey L Schwartz; Cecilia M Giachelli; Buddy D Ratner
Journal:  J Biomed Mater Res A       Date:  2004-07-01       Impact factor: 4.396

Review 8.  Nephrocalcinosis: molecular insights into calcium precipitation within the kidney.

Authors:  John A Sayer; Georgina Carr; Nicholas L Simmons
Journal:  Clin Sci (Lond)       Date:  2004-06       Impact factor: 6.124

9.  Aggregation and dispersion characteristics of calcium oxalate monohydrate: effect of urinary species.

Authors:  Kimberly G Christmas; Laurie B Gower; Saeed R Khan; Hassan El-Shall
Journal:  J Colloid Interface Sci       Date:  2002-12-01       Impact factor: 8.128

10.  Osteopontin is a critical inhibitor of calcium oxalate crystal formation and retention in renal tubules.

Authors:  Jeffrey A Wesson; Richard J Johnson; Marrilda Mazzali; Anne M Beshensky; Susan Stietz; Ceci Giachelli; Lucy Liaw; Charles E Alpers; William G Couser; Jack G Kleinman; Jeremy Hughes
Journal:  J Am Soc Nephrol       Date:  2003-01       Impact factor: 10.121

View more
  4 in total

1.  In situ flow cell platform for examining calcium oxalate and calcium phosphate crystallization on films of basement membrane extract in the presence of urinary 'inhibitors'.

Authors:  Cary A Kuliasha; Douglas Rodriguez; Archana Lovett; Laurie B Gower
Journal:  CrystEngComm       Date:  2020-02-05       Impact factor: 3.545

Review 2.  Liquid-Liquid Phase Separation in Nucleation Process of Biomineralization.

Authors:  Da Qin; Zhen He; Peng Li; Shutian Zhang
Journal:  Front Chem       Date:  2022-02-04       Impact factor: 5.221

3.  Comparison of Synthetic vs. Biogenic Polymeric Process-Directing Agents for Intrafibrillar Mineralization of Collagen.

Authors:  Neha Saxena; Joshua Mizels; Maegan A Cremer; Vanessa Guarnizo; Douglas E Rodriguez; Laurie B Gower
Journal:  Polymers (Basel)       Date:  2022-02-16       Impact factor: 4.329

4.  Multimodal imaging reveals a unique autofluorescence signature of Randall's plaque.

Authors:  Seth Winfree; Courtney Weiler; Sharon B Bledsoe; Tony Gardner; André J Sommer; Andrew P Evan; James E Lingeman; Amy E Krambeck; Elaine M Worcester; Tarek M El-Achkar; James C Williams
Journal:  Urolithiasis       Date:  2020-10-07       Impact factor: 3.436

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.